Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients.

Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P.

Arch Surg. 1994 Nov;129(11):1204-10.

PMID:
7979954
[PubMed - indexed for MEDLINE]
2.

Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.

Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA.

Ann Surg. 1994 Nov;220(5):601-9.

PMID:
7979607
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group.

Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE.

Arch Surg. 1999 Sep;134(9):977-83.

PMID:
10487593
[PubMed - indexed for MEDLINE]
4.

PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.

Washburn WK, Otsu I, Gottschalk R, Monaco AP.

J Surg Res. 1996 May;62(2):179-83.

PMID:
8632636
[PubMed - indexed for MEDLINE]
5.

A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients.

McKenzie R, Sharifi-Azad S, Dershwitz M, Miguel R, Joslyn AF, Tantisira B, Rosenblum F, Rosow CE, Downs JB, Bowie JR, et al.

J Clin Anesth. 1993 Jan-Feb;5(1):30-6.

PMID:
8442964
[PubMed - indexed for MEDLINE]
6.

Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice.

Niederman R, Kelderman H, Socransky S, Ostroff G, Genco C, Kent R Jr, Stashenko P.

Arch Oral Biol. 2002 Aug;47(8):613-8.

PMID:
12221019
[PubMed - indexed for MEDLINE]
8.

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.

Abraham E, Baughman R, Fletcher E, Heard S, Lamberti J, Levy H, Nelson L, Rumbak M, Steingrub J, Taylor J, Park YC, Hynds JM, Freitag J.

Crit Care Med. 1999 Aug;27(8):1478-85.

PMID:
10470753
[PubMed - indexed for MEDLINE]
9.

Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.

Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA.

J Clin Anesth. 1998 Mar;10(2):145-52.

PMID:
9524901
[PubMed - indexed for MEDLINE]
10.
11.
12.

Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan).

de Felippe Júnior J, da Rocha e Silva Júnior M, Maciel FM, Soares Ade M, Mendes NF.

Surg Gynecol Obstet. 1993 Oct;177(4):383-8.

PMID:
8211583
[PubMed - indexed for MEDLINE]
13.

Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.

Lizogub VG, Riley DS, Heger M.

Explore (NY). 2007 Nov-Dec;3(6):573-84.

PMID:
18005909
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.

LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC Jr, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.

Clin Ther. 2007 Aug;29(8):1579-90; discussion 1577-8.

PMID:
17919541
[PubMed - indexed for MEDLINE]
15.

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.

Kereiakes DJ, Kleiman NS, Ambrose J, Cohen M, Rodriguez S, Palabrica T, Herrmann HC, Sutton JM, Weaver WD, McKee DB, Fitzpatrick V, Sax FL.

J Am Coll Cardiol. 1996 Mar 1;27(3):536-42.

PMID:
8606262
[PubMed - indexed for MEDLINE]
Free Article
16.

Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.

Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A.

Spine (Phila Pa 1976). 2008 Nov 15;33(24):2577-80. doi: 10.1097/BRS.0b013e318188b9c5.

PMID:
19011538
[PubMed - indexed for MEDLINE]
17.

Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.

Patchen ML, Liang J, Vaudrain T, Martin T, Melican D, Zhong S, Stewart M, Quesenberry PJ.

Stem Cells. 1998;16(3):208-17.

PMID:
9617896
[PubMed - indexed for MEDLINE]
Free Article
18.

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, Postier R, Hempelmann G, Butler T, Martin E, Zwingelstein C, Percell S, Shu V, Leighton A, Creasey AA.

Crit Care Med. 2001 Nov;29(11):2081-9.

PMID:
11700399
[PubMed - indexed for MEDLINE]
19.
20.

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT; Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research and Education Foundation (IREF) Investigators.

J Thorac Cardiovasc Surg. 2003 Jun;125(6):1481-92.

PMID:
12830070
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk